 | • レポートコード：QFJ1-4070 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、クリプトコッカス症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アムホテリシンB、フルシトシン、フルコナゾール）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・クリプトコッカス症治療の市場動向 ・企業の競争状況、市場シェア ・クリプトコッカス症治療の種類別市場規模と予測2016-2027（アムホテリシンB、フルシトシン、フルコナゾール） ・クリプトコッカス症治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、ドラッグストア、その他） ・クリプトコッカス症治療の北米市場規模2016-2027（アメリカ、カナダ） ・クリプトコッカス症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・クリプトコッカス症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・クリプトコッカス症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・クリプトコッカス症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bristol-Myers Squibb、Abbott Laboratories、Pfizer、Glenmark Pharmaceuticals、Bausch Health、Johnson & Johnson、Novartis AG、Janssen Biotech、Sigmapharm Laboratories） ・結論 |
Cryptococcosis, also known as cryptococcal disease, is a potentially fatal fungal disease. It is caused by one of two species; Cryptococcus neoformans and Cryptococcus gattii.
Market Analysis and Insights: Global Cryptococcosis Treatment Market
The global Cryptococcosis Treatment market size is projected to reach US$ 4926.2 million by 2027, from US$ 4021 million in 2020, at a CAGR of 2.5% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cryptococcosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cryptococcosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cryptococcosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cryptococcosis Treatment market.
Global Cryptococcosis Treatment Scope and Market Size
Cryptococcosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cryptococcosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Amphotericin B
Flucytosine
Fluconazole
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Store
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bristol-Myers Squibb
Abbott Laboratories
Pfizer
Glenmark Pharmaceuticals
Bausch Health
Johnson & Johnson
Novartis AG
Janssen Biotech
Sigmapharm Laboratories
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cryptococcosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Amphotericin B
1.2.3 Flucytosine
1.2.4 Fluconazole
1.3 Market by Application
1.3.1 Global Cryptococcosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Store
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cryptococcosis Treatment Market Perspective (2016-2027)
2.2 Cryptococcosis Treatment Growth Trends by Regions
2.2.1 Cryptococcosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cryptococcosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Cryptococcosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Cryptococcosis Treatment Industry Dynamic
2.3.1 Cryptococcosis Treatment Market Trends
2.3.2 Cryptococcosis Treatment Market Drivers
2.3.3 Cryptococcosis Treatment Market Challenges
2.3.4 Cryptococcosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cryptococcosis Treatment Players by Revenue
3.1.1 Global Top Cryptococcosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Cryptococcosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Cryptococcosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cryptococcosis Treatment Revenue
3.4 Global Cryptococcosis Treatment Market Concentration Ratio
3.4.1 Global Cryptococcosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cryptococcosis Treatment Revenue in 2020
3.5 Cryptococcosis Treatment Key Players Head office and Area Served
3.6 Key Players Cryptococcosis Treatment Product Solution and Service
3.7 Date of Enter into Cryptococcosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cryptococcosis Treatment Breakdown Data by Type
4.1 Global Cryptococcosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Cryptococcosis Treatment Forecasted Market Size by Type (2022-2027)
5 Cryptococcosis Treatment Breakdown Data by Application
5.1 Global Cryptococcosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Cryptococcosis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cryptococcosis Treatment Market Size (2016-2027)
6.2 North America Cryptococcosis Treatment Market Size by Type
6.2.1 North America Cryptococcosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Cryptococcosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Cryptococcosis Treatment Market Size by Type (2016-2027)
6.3 North America Cryptococcosis Treatment Market Size by Application
6.3.1 North America Cryptococcosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Cryptococcosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Cryptococcosis Treatment Market Size by Application (2016-2027)
6.4 North America Cryptococcosis Treatment Market Size by Country
6.4.1 North America Cryptococcosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Cryptococcosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cryptococcosis Treatment Market Size (2016-2027)
7.2 Europe Cryptococcosis Treatment Market Size by Type
7.2.1 Europe Cryptococcosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Cryptococcosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Cryptococcosis Treatment Market Size by Type (2016-2027)
7.3 Europe Cryptococcosis Treatment Market Size by Application
7.3.1 Europe Cryptococcosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Cryptococcosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Cryptococcosis Treatment Market Size by Application (2016-2027)
7.4 Europe Cryptococcosis Treatment Market Size by Country
7.4.1 Europe Cryptococcosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Cryptococcosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cryptococcosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Cryptococcosis Treatment Market Size by Type
8.2.1 Asia-Pacific Cryptococcosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cryptococcosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cryptococcosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Cryptococcosis Treatment Market Size by Application
8.3.1 Asia-Pacific Cryptococcosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cryptococcosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cryptococcosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Cryptococcosis Treatment Market Size by Region
8.4.1 Asia-Pacific Cryptococcosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cryptococcosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cryptococcosis Treatment Market Size (2016-2027)
9.2 Latin America Cryptococcosis Treatment Market Size by Type
9.2.1 Latin America Cryptococcosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Cryptococcosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Cryptococcosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Cryptococcosis Treatment Market Size by Application
9.3.1 Latin America Cryptococcosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Cryptococcosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Cryptococcosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Cryptococcosis Treatment Market Size by Country
9.4.1 Latin America Cryptococcosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Cryptococcosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cryptococcosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Cryptococcosis Treatment Market Size by Type
10.2.1 Middle East & Africa Cryptococcosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cryptococcosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cryptococcosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Cryptococcosis Treatment Market Size by Application
10.3.1 Middle East & Africa Cryptococcosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cryptococcosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cryptococcosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Cryptococcosis Treatment Market Size by Country
10.4.1 Middle East & Africa Cryptococcosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cryptococcosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Cryptococcosis Treatment Introduction
11.1.4 Bristol-Myers Squibb Revenue in Cryptococcosis Treatment Business (2016-2021)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Cryptococcosis Treatment Introduction
11.2.4 Abbott Laboratories Revenue in Cryptococcosis Treatment Business (2016-2021)
11.2.5 Abbott Laboratories Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Cryptococcosis Treatment Introduction
11.3.4 Pfizer Revenue in Cryptococcosis Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Glenmark Pharmaceuticals
11.4.1 Glenmark Pharmaceuticals Company Details
11.4.2 Glenmark Pharmaceuticals Business Overview
11.4.3 Glenmark Pharmaceuticals Cryptococcosis Treatment Introduction
11.4.4 Glenmark Pharmaceuticals Revenue in Cryptococcosis Treatment Business (2016-2021)
11.4.5 Glenmark Pharmaceuticals Recent Development
11.5 Bausch Health
11.5.1 Bausch Health Company Details
11.5.2 Bausch Health Business Overview
11.5.3 Bausch Health Cryptococcosis Treatment Introduction
11.5.4 Bausch Health Revenue in Cryptococcosis Treatment Business (2016-2021)
11.5.5 Bausch Health Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Cryptococcosis Treatment Introduction
11.6.4 Johnson & Johnson Revenue in Cryptococcosis Treatment Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Cryptococcosis Treatment Introduction
11.7.4 Novartis AG Revenue in Cryptococcosis Treatment Business (2016-2021)
11.7.5 Novartis AG Recent Development
11.8 Janssen Biotech
11.8.1 Janssen Biotech Company Details
11.8.2 Janssen Biotech Business Overview
11.8.3 Janssen Biotech Cryptococcosis Treatment Introduction
11.8.4 Janssen Biotech Revenue in Cryptococcosis Treatment Business (2016-2021)
11.8.5 Janssen Biotech Recent Development
11.9 Sigmapharm Laboratories
11.9.1 Sigmapharm Laboratories Company Details
11.9.2 Sigmapharm Laboratories Business Overview
11.9.3 Sigmapharm Laboratories Cryptococcosis Treatment Introduction
11.9.4 Sigmapharm Laboratories Revenue in Cryptococcosis Treatment Business (2016-2021)
11.9.5 Sigmapharm Laboratories Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cryptococcosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Amphotericin B
Table 3. Key Players of Flucytosine
Table 4. Key Players of Fluconazole
Table 5. Global Cryptococcosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cryptococcosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cryptococcosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cryptococcosis Treatment Market Share by Regions (2016-2021)
Table 9. Global Cryptococcosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cryptococcosis Treatment Market Share by Regions (2022-2027)
Table 11. Cryptococcosis Treatment Market Trends
Table 12. Cryptococcosis Treatment Market Drivers
Table 13. Cryptococcosis Treatment Market Challenges
Table 14. Cryptococcosis Treatment Market Restraints
Table 15. Global Cryptococcosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cryptococcosis Treatment Market Share by Players (2016-2021)
Table 17. Global Top Cryptococcosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cryptococcosis Treatment as of 2020)
Table 18. Ranking of Global Top Cryptococcosis Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cryptococcosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cryptococcosis Treatment Product Solution and Service
Table 22. Date of Enter into Cryptococcosis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cryptococcosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cryptococcosis Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Cryptococcosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cryptococcosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cryptococcosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cryptococcosis Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Cryptococcosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cryptococcosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cryptococcosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cryptococcosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cryptococcosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cryptococcosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cryptococcosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cryptococcosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cryptococcosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cryptococcosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cryptococcosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cryptococcosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cryptococcosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cryptococcosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cryptococcosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cryptococcosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cryptococcosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cryptococcosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cryptococcosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cryptococcosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cryptococcosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cryptococcosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cryptococcosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cryptococcosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cryptococcosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cryptococcosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cryptococcosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cryptococcosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cryptococcosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cryptococcosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cryptococcosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cryptococcosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bristol-Myers Squibb Company Details
Table 63. Bristol-Myers Squibb Business Overview
Table 64. Bristol-Myers Squibb Cryptococcosis Treatment Product
Table 65. Bristol-Myers Squibb Revenue in Cryptococcosis Treatment Business (2016-2021) & (US$ Million)
Table 66. Bristol-Myers Squibb Recent Development
Table 67. Abbott Laboratories Company Details
Table 68. Abbott Laboratories Business Overview
Table 69. Abbott Laboratories Cryptococcosis Treatment Product
Table 70. Abbott Laboratories Revenue in Cryptococcosis Treatment Business (2016-2021) & (US$ Million)
Table 71. Abbott Laboratories Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Cryptococcosis Treatment Product
Table 75. Pfizer Revenue in Cryptococcosis Treatment Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Glenmark Pharmaceuticals Company Details
Table 78. Glenmark Pharmaceuticals Business Overview
Table 79. Glenmark Pharmaceuticals Cryptococcosis Treatment Product
Table 80. Glenmark Pharmaceuticals Revenue in Cryptococcosis Treatment Business (2016-2021) & (US$ Million)
Table 81. Glenmark Pharmaceuticals Recent Development
Table 82. Bausch Health Company Details
Table 83. Bausch Health Business Overview
Table 84. Bausch Health Cryptococcosis Treatment Product
Table 85. Bausch Health Revenue in Cryptococcosis Treatment Business (2016-2021) & (US$ Million)
Table 86. Bausch Health Recent Development
Table 87. Johnson & Johnson Company Details
Table 88. Johnson & Johnson Business Overview
Table 89. Johnson & Johnson Cryptococcosis Treatment Product
Table 90. Johnson & Johnson Revenue in Cryptococcosis Treatment Business (2016-2021) & (US$ Million)
Table 91. Johnson & Johnson Recent Development
Table 92. Novartis AG Company Details
Table 93. Novartis AG Business Overview
Table 94. Novartis AG Cryptococcosis Treatment Product
Table 95. Novartis AG Revenue in Cryptococcosis Treatment Business (2016-2021) & (US$ Million)
Table 96. Novartis AG Recent Development
Table 97. Janssen Biotech Company Details
Table 98. Janssen Biotech Business Overview
Table 99. Janssen Biotech Revenue in Cryptococcosis Treatment Business (2016-2021) & (US$ Million)
Table 100. Janssen Biotech Recent Development
Table 101. Sigmapharm Laboratories Company Details
Table 102. Sigmapharm Laboratories Business Overview
Table 103. Sigmapharm Laboratories Cryptococcosis Treatment Product
Table 104. Sigmapharm Laboratories Revenue in Cryptococcosis Treatment Business (2016-2021) & (US$ Million)
Table 105. Sigmapharm Laboratories Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cryptococcosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Amphotericin B Features
Figure 3. Flucytosine Features
Figure 4. Fluconazole Features
Figure 5. Global Cryptococcosis Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Drug Store Case Studies
Figure 9. Other Case Studies
Figure 10. Cryptococcosis Treatment Report Years Considered
Figure 11. Global Cryptococcosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cryptococcosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cryptococcosis Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Cryptococcosis Treatment Market Share by Regions (2022-2027)
Figure 15. Global Cryptococcosis Treatment Market Share by Players in 2020
Figure 16. Global Top Cryptococcosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cryptococcosis Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cryptococcosis Treatment Revenue in 2020
Figure 18. Global Cryptococcosis Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Cryptococcosis Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cryptococcosis Treatment Market Share by Type (2016-2027)
Figure 22. North America Cryptococcosis Treatment Market Share by Application (2016-2027)
Figure 23. North America Cryptococcosis Treatment Market Share by Country (2016-2027)
Figure 24. United States Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cryptococcosis Treatment Market Share by Type (2016-2027)
Figure 28. Europe Cryptococcosis Treatment Market Share by Application (2016-2027)
Figure 29. Europe Cryptococcosis Treatment Market Share by Country (2016-2027)
Figure 30. Germany Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cryptococcosis Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cryptococcosis Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cryptococcosis Treatment Market Share by Region (2016-2027)
Figure 40. China Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cryptococcosis Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Cryptococcosis Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Cryptococcosis Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cryptococcosis Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cryptococcosis Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cryptococcosis Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cryptococcosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Cryptococcosis Treatment Business (2016-2021)
Figure 60. Abbott Laboratories Revenue Growth Rate in Cryptococcosis Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Cryptococcosis Treatment Business (2016-2021)
Figure 62. Glenmark Pharmaceuticals Revenue Growth Rate in Cryptococcosis Treatment Business (2016-2021)
Figure 63. Bausch Health Revenue Growth Rate in Cryptococcosis Treatment Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Cryptococcosis Treatment Business (2016-2021)
Figure 65. Novartis AG Revenue Growth Rate in Cryptococcosis Treatment Business (2016-2021)
Figure 66. Janssen Biotech Revenue Growth Rate in Cryptococcosis Treatment Business (2016-2021)
Figure 67. Sigmapharm Laboratories Revenue Growth Rate in Cryptococcosis Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界のクリプトコックス症治療薬市場規模・現状・予測（2021年-2027年） Cryptococcosis is a fungal disease.It is caused by Cryptococcus neococcus, or Cryptococcus gattii.The disease is spread by inhaling a fungus linked to birds.It can infect animals and humans.It infects humans by inhaling fungus.The fungus mainly affects the lungs, but it can spread to the brain, call…- クリプトコッカス薬のグローバル市場：規模・現状・予測2019-2025 Cryptococcosis is a fungal disease.It is caused by Cryptococcus neococcus, or Cryptococcus gattii.The disease is spread by inhaling a fungus linked to birds.It can infect animals and humans.It infects humans by inhaling fungus.The fungus mainly affects the lungs, but it can spread to the brain, call…
- クリプトコッカス薬のグローバル市場：規模・現状・予測2019-2025 Cryptococcosis is a fungal disease.It is caused by Cryptococcus neococcus, or Cryptococcus gattii.The disease is spread by inhaling a fungus linked to birds.It can infect animals and humans.It infects humans by inhaling fungus.The fungus mainly affects the lungs, but it can spread to the brain, call…
- 世界の好中球減少症生物学的製剤治療市場規模・現状・予測（2021年-2027年） Neutropenia is a clinical condition characterized by a decrease in neutrophil count in the blood, resulting in a higher risk of developing serious infections. A neutrophil is a type of white blood cell, which helps in fighting infections. The major causes of neutropenia include cancer chemotherapy,…
- 世界のピーナッツアレルギー治療市場規模・現状・予測（2021年-2027年） Peanuts are important food allergens and can cause extremely severe allergies. Symptoms of peanut allergy include: reduced blood pressure, swelling of the face and throat, which can hinder breathing and cause shock. Market Analysis and Insights: Global Peanut Allergy Treatment Market The global Pean…